AXIM Biotech: New Clinical Program Featured in National

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
143
AXIM Biotech: New Clinical Program Featured in National Ophthalmology Publication Reignites Hope for Glaucoma Cannabis Therapy -- SECFilings.com

REDONDO BEACH, CA--(Marketwired - Apr 12, 2017) -  SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing AXIM® Biotechnologies Inc.'s ( OTCQB : AXIM ) progress in ophthalmology.

Medical cannabis has gained widespread acceptance for several different medical indications, but ophthalmology isn't one of them - with many members of the community recommending against the use of the drug. While research in the 1970s may have been inconclusive, new research suggests that the interaction of multiple cannabinoids could play a multi-factor role in reducing intraocular pressure ("IOP") and inflammatory conditions in the back of the eye.

Researchers began studying medical cannabis for the treatment of glaucoma in the 1970s after noting that the drug's use lowered intraocular pressure -- or IOP -- which causes nerve damage that can lead to vision loss or blindness. While the National Eye Institute and other organizations supported early research in the late 1970s, they discontinued these studies and moved onto prescription and laser treatment options, even as medical cannabis research advanced.

Despite its potential benefits, the ophthalmology industry remains staunchly opposed to the use of medical cannabis to treat eye disorders. The American Glaucoma Society issued a statement in 2009 recommending against medical cannabis treatment for glaucoma, saying that the drug produces only short-term results and the adverse side-effects may not be worth it. These sentiments have been mirrored in more recent publications and advisories as well.

AXIM Biotech, a company specializing in cannabinoid research and development, is committed to developing cannabinoid-based therapies for glaucoma and dry eye. These research efforts are led by Dr. Robert Ritch, MD, who is a noted glaucoma specialist. This potentially groundbreaking research was featured recently in renowned medical outlet, Ophthalmology Innovation Summit .

Dr. Ritch became interested in the effects of medical cannabis on glaucoma when a 73 year old patient with IOPs usually in the 20s came into the office with a reading of 13mm Hg. The individual admitted to smoking marijuana the night prior, but not in the morning, which seemed to contradict popular beliefs that the IOP-lowering effects of medical cannabis only lasted a few hours at best -- this appeared to last through the next day.

Dr. Ritch's research centers on the theory that multiple cannabinoids act together in different ways that could affect IOP and other metrics. For example, there could be a drop or other formulation that not only lowers IOP but also provides neuroprotection, providing a double mechanism of action -- one in the front of the eye and one in back of the eye. Devices like the Triggerfish -- a contact lens sensor -- could then be used to collect efficacy data over time.

Please follow the link to read the full article: http://analysis.secfilings.com/articles/160-a...is-therapy

About SECFilings.com

Founded in 2004, SECFilings.com provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx .

SEC Filings.com Paul Archie 406-862-2242 parchie@secfilings.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innogen's Arcera Deal Tests Its GLP-1 Global Reach

Updated Category News Views 100

A License Deal With Actual Cash Attached Drug licensing announcements can smell like expensive perfume: plenty of promise, hard to tell what is really in the bottle. This one at least arrives with a concrete number. Innogen Pharmaceuticals will receive US$38 million in upfront and near-term milestone payments from Arcera Life Sciences for Efsubaglutide Alfa, including a...

Continue Reading
Markley’s Lowell Campus Turns Data Land Into Arboretum

Updated Category News Views 279

Server halls rarely get credited with restoring a landscape, which is why Markley’s Lowell campus caught my eye. On November 18, 2026, the company said its Lowell data center campus had earned Level I arboretum accreditation from the ArbNet Arboretum Accreditation Program. ArbNet describes itself as the only international accreditation program specifically for arboreta,...

Continue Reading
Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 155

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 128

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Vector Adds Mesa Division 10 Veteran for Arizona Growth

Updated Category News Views 140

A toilet-partition deal rarely raises eyebrows, but this one has the sturdy logic investors ought to notice. Vector Building Products has acquired Mesa-based Partitions & Accessories Co., a Division 10 specialist that has served Arizona contractors since 1978. It is not glamorous work. It is, however, the sort of necessary, specification-driven business that gets embedded...

Continue Reading
Mar-Jac's Safety Milestone Carries Real Operational Weight

Updated Category News Views 125

Four million worked hours without a lost-time accident is the sort of number that ought to make people pause, especially in poultry processing. Mar-Jac Poultry’s Gainesville facility earned Workplace Safety recognition from the Greater Hall Chamber of Commerce after reaching that mark, and this is one corporate achievement that deserves a little less eye-rolling than...

Continue Reading
Linq's $90M Bet on the Infrastructure Behind AI Agents

Updated Category News Views 201

Ninety million dollars just landed on the least glamorous part of the AI-agent rush: the pipes. Linq, the San Francisco private company, announced the round on November 18, 2026, led by Andreessen Horowitz, with returning backing from TQ Ventures, Mucker Capital and Abstract, plus new money from Anthos and Left Lane Capital. Ben Horowitz is joining the board. That is a...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 198

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 84

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 10

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading

Top 5 Most Recently Viewed Articles

Mori Building Boosts Investment in SL Green’s Premier Tower

Updated Category News Views 252

Mori Building Increases Stake in Iconic One Vanderbilt Avenue In a significant development within New York’s skyline, Mori Building Co., Ltd. has expanded its investment in One Vanderbilt Avenue, acquiring an additional 5.0% interest. This comes on the heels of their earlier investment of 11.0% in 2024, marking a strong commitment to this architectural marvel situated...

Continue Reading
Vegamour Welcomes Michelle Miller as Chief Marketing Officer

Updated Category News Views 415

Vegamour Welcomes New Chief Marketing Officer Michelle Miller Vegamour is excited to announce the appointment of Michelle Miller as its first Chief Marketing Officer. A well-regarded figure in the beauty industry, Michelle brings years of experience and a proven track record of success to the company. Experience and Achievements of Michelle Miller Before joining Vegamour,...

Continue Reading
Streamlined Financing Solutions Transform Insurance Payments

Updated Category News Views 107

Revolutionizing Insurance Payments with Innovative Solutions FIRST Insurance Funding, a division of Lake Forest Bank & Trust Company, N.A., has been at the forefront of premium financing for many years. Their recent integration with ePayPolicy is set to elevate the insurance payment process, making it more accessible and user-friendly for providers and insureds alike....

Continue Reading
Range Resources Delivers Strong Q1 Results with Growth Plans

Updated Category News Views 238

Impact of Q1 2025 Results on Range Resources Range Resources Corporation (NYSE: RRC) recently revealed its first quarter financial performance, showcasing robust operating results. The company reported cash flow from operating activities reaching $330 million, highlighting strong operational efficiency. Financial Highlights for the First Quarter Key Financial Metrics In...

Continue Reading
Investing in Tomorrow: The Untapped Potential of DexCom and Roku

Updated Category News Views 122

Investing in stocks can feel like a rollercoaster ride, especially when markets take a nosedive. Historical trends remind us that, over time, stocks often bounce back. Smart investors seize opportunities during downturns to snag quality shares at bargain prices. This principle of 'buy low' remains as relevant as ever. DexCom's Dip: Opportunity or Red Flag? DexCom’s...

Continue Reading